New Product Development
The Point of Care (PoC) molecular diagnostics market is forecasted to hit USD 5,295 Million by 2025. Then, it is likely to grow to USD 13,733.8 Million by 2035 with a CAGR of 10% over time. Things driving this growth include more people with long-term illnesses, bigger need for home tests, and the government backing …
Continue reading “Point-of-care Molecular Diagnostics Market to Hit USD 13.7B by 2035”
The point-of-care molecular diagnostics market is predicted to secure a valuation of USD 4.4 billion in 2023 and is rising to USD 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …
The global point-of-care molecular diagnostics market is poised for remarkable growth, with an estimated valuation of USD 4.4 billion in 2023. By 2033, the market is projected to reach USD 11.1 billion, representing a robust compound annual growth rate (CAGR) of 9.7% over the forecast period. This growth underscores the increasing demand for rapid, accurate, …
The future of healthcare is being shaped by rapid and accurate diagnostics, and the Point-of-Care Molecular Diagnostics Market is leading the charge. This market is poised for significant growth, with a projected value of USD 11.1 billion by 2033. Starting from a valuation of USD 4.4 billion in 2023, the market is expected to expand …
The Point of Care Molecular Diagnostics Market is poised for a remarkable expansion, fueled by the increasing demand for rapid and accurate diagnoses at the patient’s bedside. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to skyrocket from a valuation of US$4.4 billion in …
The Global Point of Care Molecular Diagnostics Industry is poised for a surge in growth, according to a recent market analysis by Future Market Insights (FMI). With a projected valuation of US$4.4 billion in 2023, the market is expected to experience significant expansion, reaching a staggering US$11.1 billion by 2033. This translates to a robust …
The Global Point of Care Molecular Diagnostics Industry is positioned for unprecedented expansion, according to the latest forecast by Future Market Insights (FMI). With a projected valuation of US$ 4.4 billion in 2023, this dynamic industry is on track to reach an impressive US$ 11.1 billion by 2033, reflecting a robust Compound Annual Growth Rate …
The Global Point Of Care Molecular Diagnostics Industry is on the brink of substantial expansion, with a projected valuation of US$ 4.4 billion in 2023, and it is poised to soar to US$ 11.1 billion by 2033, demonstrating a robust Compound Annual Growth Rate (CAGR) of 9.7% throughout the forecast period. This exciting trajectory reflects …
The point-of-care molecular diagnostics market is predicted to secure a valuation of US$ 4.4 billion in 2023 and will rise to US$ 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. The Point-of-Care Molecular Diagnostics Market is expected to grow significantly over the forecast period of 2023 to 2033, …
The Point-Of-Care Molecular Diagnostics Market is predicted to secure a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …
